Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

China · Delayed Price · Currency is CNY

1.360

-0.050 (-3.55%)

Jun 11, 2026, 11:20 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Traditional Chinese Medicine, Western Medicine and Medical Devices	4.22B	4.24B	3.88B	3.43B	3.41B
Traditional Chinese Medicine, Western Medicine and Medical Devices Growth	-0.51%	9.41%	12.89%	0.77%	-26.98%
Health Food and Food	500.27M	437.48M	502.79M	324.58M	184.23M
Health Food and Food Growth	14.35%	-12.99%	54.90%	76.18%	-1.49%
Property Leasing and Sales and Others	532.62M	510.55M	494.89M	421.95M	560.99M
Property Leasing and Sales and Others Growth	4.32%	3.16%	17.29%	-24.79%	0.35%
Total	5.25B	5.19B	4.87B	4.18B	4.15B
Total Growth	1.22%	6.47%	16.60%	0.67%	-23.27%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	5.25B	5.19B	4.87B	4.18B	4.15B
China Growth	1.22%	6.47%	16.60%	0.67%	-23.27%
Total	5.25B	5.19B	4.87B	4.18B	4.15B
Total Growth	1.22%	6.47%	16.60%	0.67%	-23.27%

Source: S&P Global Market Intelligence.